300049SZSE

Furuide Medical: 2025 Independent Director's Work Report (Guo Jinlong)

Inner Mongolia Furui Medical Science Co., Ltd.·March 24, 2026

✨ AI Summary

This report details the work of Furuide Medical's Independent Director, Guo Jinlong, for 2025. The director attended 4 board and 3 shareholder meetings, and participated in Audit Committee meetings reviewing financial reports. Key activities included communication with internal audit and accounting firms, and field investigations. The director focused on information disclosure, shareholder rights, and professional development, supporting the company's IPO process and corporate governance enhancement.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

As the independent director of Furuide Medical Technology Co., Ltd. (hereinafter referred to as "the Company"), I, during my term of office, in accordance with the "Company Law of the People's Republic of China," "Shenzhen Stock Exchange Listing Rules," "Corporate Governance Guidelines for Listed Companies," "Independent Director Work Rules," and other relevant laws and regulations, actively performed my duties and responsibilities.

This year's work situation is as follows:

I. Attendance at Board and Shareholder Meetings

In 2025, I participated in a total of 4 board meetings and 3 shareholder meetings. I did not attend two consecutive meetings due to personal reasons. I believe that the convening of board meetings and shareholder meetings complies with the prescribed procedures.

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.